Acquired myasthenia gravis (MG) is a disorder of neuromuscular transmission
in which muscle weakness results from an autoantibody mediated depletion o
f acetylcholine receptors (AChR) at the neuromuscular junction. Experimenta
l autoimmune myasthenia gravis, described in rodents and rabbits, has provi
ded a good model of the effects of the autoimmune response against AChR and
has shown that the specificities of the immune response in MG are those th
at would be obtained by immunization with native AChR. It has provided litt
le information, however, about what initiates and sustains the immune respo
nse in MG. Acquired MG occurs spontaneously in dogs and may be the most com
mon neuromuscular disorder that can be diagnosed in this species. As in hum
an MG, an autoimmune response against AChR has been demonstrated and AChR a
utoantibodies have been implicated in the pathogenesis. The variability in
clinical presentation, methods of diagnosis, and occurrence with other auto
immune diseases and neoplasia are identical to that of humans. Future studi
es of spontaneous canine autoimmune MG may provide clues to the determinati
on of what factors initiate and sustain the autoimmune response to AChR, an
d in the study of specific suppression of the autoimmune response against A
ChR. (C) 1999 Elsevier Science B.V. All rights reserved.